Rhabdomyolysis is a clinical and laboratory syndrome that is caused by various etiologies,
involving the skeletal muscle. Clarithromycin, like other macrolides, is an inhibitor of …

Fibric acid derivatives and statins have been increasingly recognized as causes of
rhabdomyolysis and acute renal failure. We report severe rhabdomyolysis and acute renal …

An elderly woman with a history of hypertension, hypothyroidism, mesenteric vein
thrombosis, depression and hyperlipidaemia on statins for> 9 years presented with new …

OBJECTIVE: To report a case of severe myopathy associated with concomitant simvastatin
and amiodarone therapy. CASE SUMMARY: A 63-year-old white man with underlying …

All available 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors
(“statins”) have been implicated in causing rhabdomyolysis, either as monotherapy or in …

OBJECTIVE: To report a case of rhabdomyolysis resulting from concomitant use of
clarithromycin and simvastatin. CASE SUMMARY: A 64-year-old African-American man was …

Drug induced myopathy has been reported with the use of fibric acid derivatives,
hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors and nicotinic acid. Over …

Fear of muscle toxicity remains a major reason that patients with hyperlipidemia are
undertreated. Recent evaluations of statin-induced rhabdomyolysis offer new insights on the …

Renal failure secondary to rhabdomyolysis due to statins is quite rare. We present a case of
a 57-year-old patient who developed acute renal failure due to rhabdomyolysis secondary to …

ContextLipid-lowering agents are widely prescribed in the United States. Reliable estimates
of rhabdomyolysis risk with various lipid-lowering agents are not available. ObjectiveTo …